BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PINKvsIBBETF Comparison

ETF 1

PINK

Simplify Health Care ETF

This fund is part of

Healthcare Technology

-0.16%

Full PINK fund page

VS

ETF 2

IBB

iShares Biotechnology ETF

This fund is part of

US Health Care

-0.17%

Full IBB fund page

Simplify Health Care ETF (PINK) belongs to the Healthcare Technology segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. PINK's top 3 sector exposures are Healthcare, Non-Energy Materials and Consumer Cyclicals. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. PINK is more expensive with a Total Expense Ratio (TER) of 0.51%, versus 0.44% for IBB. PINK is up 6.64% year-to-date (YTD) with +$15M in YTD flows. IBB performs better with 12.51% YTD performance, and +$61M in YTD flows. Run a side-by-side ETF comparison of PINK and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PINK vs IBB performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 07/16/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PINK IBB	+5.72%+9.36%	+9.91%+7.38%	+6.64%+12.51%	+30.06%+44.42%	+48.34%+48.02%	n/a+18.85%
Flows	PINK IBB	+$52M+$386M	+$113M+$117M	+$15M+$61M	+$192M+$1.48B	+$246M-$816M	--$1.78B

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PINK IBB	+16.48%+22.47%	+18.08%+20.47%	+16.93%+20.37%	n/a+22.33%
Max drawdown	PINK IBB	-5.27%-7.21%	-16.68%-9.61%	-18.81%-24.82%	n/a-39.75%
Max drawdown duration	PINK IBB	22d60d	154d151d	390d377d	n/a1611d

Trading data

Create an account to view trading data

Join for free

	PINK	IBB
Last sale 7/17/2026 at 1:30 PM	$38.89	$189.76
Previous close 07/16/2026	$38.94	$189.51
Consolidated volume 07/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of June 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

PINK

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	PINK	IBB
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 7/17/2026 at 1:30 PM

Live

Closed

	PINK	IBB
Last price	$38.89	$189.76
1D performance	-0.13%	+0.13%
AuM	$377.02 M	$9.39 B
E/R	0.51%	0.44%

Characteristics

	PINK	IBB
Management strategy	Active	Passive
Provider	Simplify	iShares
Benchmark	-	ICE Biotechnology Index
N° of holdings	52	244
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	October 7, 2021	February 5, 2001
ESG	No	No

More PINK data on Trackinsight

More IBB data on Trackinsight

Exposure

Countries

PINK

USA

85.43%

Other

14.57%

IBB

USA

86.07%

Other

13.93%

Sectors

PINK

Healthcare

82.51%

Non-Energy Materi.

10.31%

Other

7.18%

IBB

Healthcare

99.79%

Other

0.21%

Diversification

PINK

Total weight of top 15 holdings out of 15

72.47%

IBB

Total weight of top 15 holdings out of 15

54.07%

Top 15 holdings

Data as of May 31, 2026

PINK

Purecycle Technologies, Inc.

10.31%

United Therapeutics Corp.

7.72%

Novo Nordisk A/S

6.56%

Eli Lilly & Co.

5.54%

Johnson & Johnson

5.21%

Jazz Pharmaceuticals Plc

4.79%

UnitedHealth Group, Inc.

4.60%

Align Technology, Inc.

4.15%

AbbVie, Inc.

4.04%

Warby Parker, Inc.

3.94%

Biohaven Ltd.

3.53%

Gilead Sciences, Inc.

3.20%

Thermo Fisher Scientific, Inc.

3.04%

10X Genomics, Inc.

2.95%

Benitec Biopharma, Inc.

2.90%

IBB

Gilead Sciences, Inc.

7.42%

Vertex Pharmaceuticals, Inc.

7.40%

Amgen, Inc.

7.13%

Regeneron Pharmaceuticals, Inc.

5.69%

Alnylam Pharmaceuticals, Inc.

3.61%

argenx SE

3.49%

Natera, Inc.

2.68%

Biogen, Inc.

2.61%

Revolution Medicines, Inc.

2.47%

Illumina, Inc.

2.20%

United Therapeutics Corp.

2.15%

Insmed, Inc.

2.07%

BeOne Medicines Ltd.

1.86%

Incyte Corp.

1.73%

Moderna, Inc.

1.55%

Frequently asked questions about PINK and IBB

How have the PINK and IBB ETFs performed in 2026?

As of July 16, 2026, PINK is up 6.64% year-to-date (YTD), while IBB has returned 12.51%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: PINK or IBB?

Year-to-date, the PINK ETF saw +$15M in flows, compared to +$61M for IBB.

Which ETF is more volatile: PINK or IBB?

Over the past year, PINK had a volatility of 18.08%, while IBB experienced 20.47%.

Which ETF is bigger: PINK or IBB?

As of July 16, 2026, PINK holds $377.02 M in assets under management (AUM), while IBB manages $9.39 B.

What sectors do the PINK and IBB ETFs invest in?

PINK leans toward sectors like Healthcare and Non-Energy Materials. Meanwhile, IBB focuses on Healthcare.

What are the top holdings of the PINK ETF and IBB ETF?

PINK top holdings include Purecycle Technologies, Inc., United Therapeutics Corp. and Novo Nordisk A/S. IBB holds in its top three: Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc. and Amgen, Inc..

PINKvsIBBETF Comparison

Simplify Health Care ETF

iShares Biotechnology ETF

PINK vs IBB performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PINK and IBB ETFs performed in 2026?

As of July 16, 2026, PINK is up 6.64% year-to-date (YTD), while IBB has returned 12.51%. That puts IBB better performer ahead so far this year.

Which ETF is attracting more investor money: PINK or IBB?

Year-to-date, the PINK ETF saw +$15M in flows, compared to +$61M for IBB.

Which ETF is more volatile: PINK or IBB?

Over the past year, PINK had a volatility of 18.08%, while IBB experienced 20.47%.

Which ETF is bigger: PINK or IBB?

As of July 16, 2026, PINK holds $377.02 M in assets under management (AUM), while IBB manages $9.39 B.

What sectors do the PINK and IBB ETFs invest in?

PINK leans toward sectors like Healthcare and Non-Energy Materials. Meanwhile, IBB focuses on Healthcare.

What are the top holdings of the PINK ETF and IBB ETF?

PINK top holdings include Purecycle Technologies, Inc., United Therapeutics Corp. and Novo Nordisk A/S. IBB holds in its top three: Gilead Sciences, Inc., Vertex Pharmaceuticals, Inc. and Amgen, Inc..

Which ETF is more diversified: PINK or IBB?

PINK holds 52 securities with 72.47% of its assets in the top 15. IBB has 244 securities and a top 15 weight of 54.07%.

Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities

Are Biotechnology ETFs In the Midst of a Comeback?

Investing in the Aging Population: A Look at Bonds and Pharma ETFs

Health is Wealth: A look at the Healthcare Sector

Biotech ETFs – Investing in Health Innovation

Biotech ETFs – Investing in Health Innovation

The ETF Industry Is Evolving Fast